Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Over the last 12 months, insiders at Bausch + Lomb Corporation have bought $505,067 and sold $0 worth of Bausch + Lomb Corporation stock.
On average, over the past 5 years, insiders at Bausch + Lomb Corporation have bought $505,067 and sold $1.35B worth of stock each year.
Highest buying activity among insiders over the last 12 months: SAUNDERS BRENT L (CEO and Chairman of the Board) — $2.02M.
The last purchase of 32,250 shares for transaction amount of $505,067 was made by SAUNDERS BRENT L (CEO and Chairman of the Board) on 2024‑08‑05.
2024-08-05 | CEO and Chairman of the Board | 32,250 0.0093% | $15.66 | $505,067 | +25.55% | |||
2022-06-01 | Sale | 9.1M 2.724% | $17.05 | $155.21M | -1.47% | |||
2022-05-10 | Sale | 70M 19.4359% | $17.05 | $1.19B | -8.60% |
Fil Ltd | $141.6M | 2.33 | 8.19M | +0.86% | +$1.21M | 0.14 | |
GoldenTree Asset Management | $81.58M | 1.34 | 4.72M | 0% | +$0 | 7.14 | |
Maple Rock Capital Partners Inc | $64.79M | 1.06 | 3.75M | 0% | +$0 | 4.1 | |
ICAHN CARL C | $60.55M | 1 | 3.5M | 0% | +$0 | 0.54 | |
River Road Asset Management | $32.66M | 0.54 | 1.89M | -2.59% | -$867,456.59 | 0.44 | |
Alberta Investment Management Corporation | $27.54M | 0.45 | 1.59M | +17.75% | +$4.15M | 0.21 | |
Citadel Advisors LLC | $27.44M | 0.45 | 1.59M | -37.72% | -$16.62M | 0.02 | |
Nomura Holdings | $21.73M | 0.36 | 1.26M | 0% | +$0 | 0.19 | |
Whitebox Advisors | $20.87M | 0.34 | 1.21M | +29.32% | +$4.73M | 2.38 | |
Freshford Capital Management Llc | $20.16M | 0.33 | 1.17M | -33.57% | -$10.19M | 3.53 | |
Laurion Capital Management LP | $17.89M | 0.29 | 1.03M | 0% | +$0 | 0.13 | |
Canada Pension Plan Investment Board | $14.73M | 0.24 | 851,675 | 0% | +$0 | 0.02 | |
Clark Estates Inc Ny | $10.68M | 0.18 | 617,500 | +11.87% | +$1.13M | 2.17 | |
Victory Capital Management Inc | $9.7M | 0.16 | 560,831 | -2.1% | -$208,274.69 | 0.01 | |
Point72 Europe London Llp | $8.77M | 0.14 | 506,909 | New | +$8.77M | 0.84 | |
Point72 Asset Management | $8.55M | 0.14 | 494,156 | New | +$8.55M | 0.01 | |
Invenomic Capital Management LP | $6.82M | 0.11 | 394,067 | New | +$6.82M | 0.37 | |
Empyrean Capital Partners | $6.66M | 0.11 | 385,000 | 0% | +$0 | 0.52 | |
Caspian Capital LP | $5.76M | 0.1 | 333,124 | 0% | +$0 | 9.37 | |
Rokos Capital Management | $5.6M | 0.09 | 323,980 | New | +$5.6M | 0.15 | |
Gabelli Funds Llc | $5.4M | 0.09 | 312,000 | +3.31% | +$173,000.00 | 0.04 | |
Woodline Partners LP | $5.36M | 0.09 | 309,965 | +0.15% | +$8,200.20 | 0.05 | |
Clearline Capital LP | $5.2M | 0.09 | 300,651 | +3.68% | +$184,712.13 | 0.51 | |
Arrowstreet Capital, Limited Partnership | $4.08M | 0.07 | 236,142 | +151.16% | +$2.46M | <0.01 | |
Raymond James Associates | $3.67M | 0.06 | 212,042 | +10.25% | +$341,086.19 | <0.01 | |
LMR PARTNERS LLP | $2.59M | 0.04 | 149,536 | -7.49% | -$209,537.62 | 0.06 | |
Ratan Capital Management LP | $2.1M | 0.04 | 121,471 | 0% | +$0 | 1.14 | |
Ameriprise Financial | $1.73M | 0.03 | 99,725 | +132.32% | +$982,639.71 | <0.0001 | |
Allianz Asset Management Gmbh | $1.73M | 0.03 | 100,000 | 0% | +$0 | <0.01 | |
Morgan Stanley | $1.66M | 0.03 | 95,931 | -30.05% | -$712,829.07 | <0.0001 | |
PDT Partners | $1.27M | 0.02 | 73,476 | +41.71% | +$374,147.16 | 0.1 | |
Brandes Investment Partners | $1.08M | 0.02 | 62,547 | -45.23% | -$893,596.82 | 0.01 | |
Bank of America | $1.03M | 0.02 | 59,582 | -49.12% | -$995,079.09 | <0.0001 | |
ExodusPoint Capital Management, LP | $945,000.00 | 0.02 | 54,596 | -62.64% | -$1.58M | 0.01 | |
GAMCO Investors | $883,857.00 | 0.02 | 51,090 | -3.95% | -$36,330.00 | 0.01 | |
Dimensional Fund Advisors | $760,785.00 | 0.01 | 43,976 | <0.01% | -$17.30 | <0.0001 | |
Susquehanna International Group | $698,643.00 | 0.01 | 40,384 | +279.16% | +$514,380.75 | <0.01 | |
Jump Financial Llc | $686,256.00 | 0.01 | 39,668 | -54.46% | -$820,573.12 | 0.01 | |
Wolverine Asset Management, LLC | $669,146.00 | 0.01 | 38,679 | 0% | +$0 | 0.06 | |
Hrt Financial Llc | $595,000.00 | 0.01 | 34,441 | New | +$595,000.00 | <0.01 | |
Balyasny Asset Management Llc | $625,637.00 | 0.01 | 36,164 | New | +$625,637.00 | <0.01 | |
UBS | $534,450.00 | 0.01 | 30,893 | +3,644.61% | +$520,177.47 | <0.0001 | |
Goldman Sachs | $577,837.00 | 0.01 | 33,401 | -52.33% | -$634,390.67 | <0.0001 | |
Mariner Llc | $421,047.00 | 0.01 | 24,338 | +21.61% | +$74,805.13 | <0.01 | |
Simplex Trading Llc | $417,000.00 | 0.01 | 24,120 | New | +$417,000.00 | 0.01 | |
State Street | $435,960.00 | 0.01 | 25,200 | +34.04% | +$110,720.00 | <0.0001 | |
Renaissance Capital | $399,215.00 | 0.01 | 23,076 | +2.99% | +$11,573.71 | 0.21 | |
Nj State Employees Deferred Compensation Plan | $441,150.00 | 0.01 | 25,500 | 0% | +$0 | 0.04 | |
Schonfeld Group | $433,278.00 | 0.01 | 25,045 | -89.53% | -$3.7M | <0.01 | |
Fore Capital Llc | $383,714.00 | 0.01 | 22,180 | New | +$383,714.00 | 2.39 |